Redeye

Xspray Pharma (Q3 review): Inspection outcome to turn the tide?

Källa: MFN
Neutral

Sammanfattning

Xspray Pharma (Q3 review): Inspection outcome to turn the tide?

Analys

Den preliminära analysen kunde inte slutföras.

VD-ord

VD-ordet kunde inte hämtas eller analyseras.

Redeye’s analyst published a Research Update on Xspray Pharma.Click here to read the articleMake sure to add Xspray Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies

About Redeye Nordic Growth AB

This is a press release from Redeye Nordic Growth AB, a equity research firm specializing in Nordic growth companies within Tech and Life Science. Redeye Nordic Growth is a part of the Redeye group, which also offers services within corporate finance advisory and fund management. https://services.redeye.se/

Attachments

Xspray Pharma (Q3 review): Inspection outcome to turn the tide?